Pulmonary transit time of cardiovascular magnetic resonance perfusion scans for quantification of cardiopulmonary haemodynamics

Abstract Aims Pulmonary transit time (PTT) is the time blood takes to pass from the right ventricle to the left ventricle via pulmonary circulation. We aimed to quantify PTT in routine cardiovascular magnetic resonance imaging perfusion sequences. PTT may help in the diagnostic assessment and characterization of patients with unclear dyspnoea or heart failure (HF). Methods and results We evaluated routine stress perfusion cardiovascular magnetic resonance scans in 352 patients, including an assessment of PTT. Eighty-six of these patients also had simultaneous quantification of N-terminal pro-brain natriuretic peptide (NTproBNP). NT-proBNP is an established blood biomarker for quantifying ventricular filling pressure in patients with presumed HF. Manually assessed PTT demonstrated low inter-rater variability with a correlation between raters >0.98. PTT was obtained automatically and correctly in 266 patients using artificial intelligence. The median PTT of 182 patients with both left and right ventricular ejection fraction >50% amounted to 6.8 s (Pulmonary transit time: 5.9–7.9 s). PTT was significantly higher in patients with reduced left ventricular ejection fraction (<40%; P < 0.001) and right ventricular ejection fraction (<40%; P < 0.0001). The area under the receiver operating characteristics curve (AUC) of PTT for exclusion of HF (NT-proBNP <125 ng/L) was 0.73 (P < 0.001) with a specificity of 77% and sensitivity of 70%. The AUC of PTT for the inclusion of HF (NT-proBNP >600 ng/L) was 0.70 (P < 0.001) with a specificity of 78% and sensitivity of 61%. Conclusion PTT as an easily, even automatically obtainable and robust non-invasive biomarker of haemodynamics might help in the evaluation of patients with dyspnoea and HF.

[1]  A. Barkat,et al.  Machine learning guided postnatal gestational age assessment using new-born screening metabolomic data in South Asia and sub-Saharan Africa , 2021, BMC Pregnancy and Childbirth.

[2]  J. McMurray,et al.  2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.

[3]  A. Hughes,et al.  Prognostic Value of Pulmonary Transit Time and Pulmonary Blood Volume Estimation Using Myocardial Perfusion CMR , 2021, JACC. Cardiovascular imaging.

[4]  B. Stieltjes,et al.  Automated Detection of Pancreatic Cystic Lesions on CT Using Deep Learning , 2021, Diagnostics.

[5]  B. Gerber,et al.  Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction. , 2021, Circulation. Cardiovascular imaging.

[6]  Jens Petersen,et al.  nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation , 2020, Nature Methods.

[7]  D. Bluemke,et al.  Reference ranges (“normal values”) for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update , 2020, Journal of Cardiovascular Magnetic Resonance.

[8]  R. Wachter,et al.  Exercise-Stress Real-time Cardiac Magnetic Resonance Imaging for Non-Invasive Characterisation of Heart Failure with Preserved Ejection Fraction: The HFpEF Stress Trial. , 2020, Circulation.

[9]  Niansheng Tang,et al.  Confidence intervals of the difference between areas under two ROC curves in matched‐pair experiments , 2020, Statistics in medicine.

[10]  B. Gerber,et al.  Pulmonary hypertension detection by computed tomography pulmonary transit time in heart failure with reduced ejection fraction. , 2019, European heart journal cardiovascular Imaging.

[11]  G. Filippatos,et al.  Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations , 2019, European journal of heart failure.

[12]  Y. Pinto,et al.  Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction , 2019, Heart.

[13]  Klaus H. Maier-Hein,et al.  nnU-Net: Self-adapting Framework for U-Net-Based Medical Image Segmentation , 2018, Bildverarbeitung für die Medizin.

[14]  R. de Caterina,et al.  Prognostic value of pulmonary blood volume by first-pass contrast-enhanced CMR in heart failure outpatients: the PROVE-HF study , 2018, European heart journal cardiovascular Imaging.

[15]  Meilan K. Han,et al.  NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort. , 2018, Respiratory medicine.

[16]  Nicola Orsini,et al.  Utilizing NT-proBNP for Eligibility and Enrichment in Trials in HFpEF, HFmrEF, and HFrEF. , 2018, JACC. Heart failure.

[17]  Michael Passick,et al.  Prolonged central circulation transit time in patients with HFpEF and HFrEF by magnetic resonance imaging , 2018, European heart journal cardiovascular Imaging.

[18]  Ingeborg H. F. Herold,et al.  Noninvasive pulmonary transit time: A new parameter for general cardiac performance , 2017, Echocardiography.

[19]  J. Cleland,et al.  What can we learn from SOCRATES: more questions than answers? , 2017, European heart journal.

[20]  M. Reisert,et al.  “Nora Imaging”: A Web-Based Platform for Medical Imaging , 2017, Neuropediatrics.

[21]  M. Mischi,et al.  Pulmonary transit time measurement by contrast-enhanced ultrasound in left ventricular dyssynchrony , 2016, Echo research and practice.

[22]  G. Filippatos,et al.  Acute heart failure: Epidemiology, risk factors, and prevention. , 2015, Revista espanola de cardiologia.

[23]  H. Marshall,et al.  Dynamic Contrast–Enhanced Magnetic Resonance Imaging in Patients with Pulmonary Arterial Hypertension , 2014, Pulmonary circulation.

[24]  M. Ugander,et al.  Pulmonary blood volume indexed to lung volume is reduced in newly diagnosed systemic sclerosis compared to normals – a prospective clinical cardiovascular magnetic resonance study addressing pulmonary vascular changes , 2013, Journal of Cardiovascular Magnetic Resonance.

[25]  R. Rose,et al.  The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors. , 2012, Journal of molecular and cellular cardiology.

[26]  M. Ugander,et al.  Pulmonary blood volume variation decreases after myocardial infarction in pigs: a quantitative and noninvasive MR imaging measure of heart failure. , 2010, Radiology.

[27]  K. Murase,et al.  Dynamic perfusion MRI: Capability for evaluation of disease severity and progression of pulmonary arterial hypertension in patients with connective tissue disease , 2008, Journal of magnetic resonance imaging : JMRI.

[28]  J. Finn,et al.  Heart failure: evaluation of cardiopulmonary transit times with time-resolved MR angiography. , 2003, Radiology.

[29]  J. Finn,et al.  Analysis of cardiopulmonary transit times at contrast material-enhanced MR imaging in patients with heart disease. , 2003, Radiology.

[30]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[31]  S. Roy,et al.  Pulmonary blood volume in mitral stenosis. , 1965, British medical journal.

[32]  E. Faraco,et al.  Determination of Pulmonary Blood Volume by Single Intravenous Injection of One Indicator in Patients with Normal and High Pulmonary Vascular Pressures , 1964, Circulation.

[33]  L. Dexter,et al.  The pulmonary blood volume in man. , 1961, The Journal of clinical investigation.

[34]  W. Milnor,et al.  Pulmonary Vascular Volume, Resistance, and Compliance in Man , 1960, Circulation.

[35]  Salim Yusuf,et al.  Predictors of mortality and morbidity in patients with chronic heart failure. , 2006, European heart journal.

[36]  J. Karl,et al.  Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. , 1999, Scandinavian journal of clinical and laboratory investigation. Supplementum.